IL-12- and IL-2-induced tumor regression in a new murine model of oral squamous-cell carcinoma is promoted by expression of the CD80 co-stimulatory molecule and interferon-γ

International Journal of Cancer

Volumn 89, Issue 2, 2000, Pages 368-374

  Thomas, Giovana R ^a   Chen, Zhong ^a   Enamorado, Ileana ^a   Bancroft, Caren ^a   Van Waes, Carter ^a  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; ANGIOGENESIS INHIBITOR; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; KILLER CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR RECOGNITION; MOUSE; MOUTH CANCER; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR REGRESSION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MOUTH TUMOR; PATHOLOGY;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIGENS, CD80; CARCINOMA, SQUAMOUS CELL; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-2; MALE; MICE; MICE, INBRED BALB C; MOUTH NEOPLASMS; RECOMBINANT PROTEINS;

EID: 0034114552     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(20000501)86:3<368::aid-ijc11>3.0.co;2-1     Document Type: Article

References (21)

1. BLISS, J., CLEAVE, V.V., MURRAY, K., WIENCIS, A., KETCHUM, M., MAYLOR, R., HAIRE, T., RESMINI, C., ABBAS, A.K. and WOLF, S.F., IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 recall response. J. Immunol., 156, 887-894 (1996).
2. BRUNDA, M.J., LUISTRO L., HENDRZAK, J.A., FOUNTOULAKIS, M., GAROTTA, G. and GATELY, M.K., Role of interferon-gamma in mediating the antitumor efficacy of interleukin-12. J. Immunother. Emphasis Tumor Immunol., 17, 71-77 (1995).
3. BURKE, F., EAST, N., UPTON, C., PATEL, K. and BLAKWILL, F.R., Interferon-gamma induces cell cycle arrest and apoptosis in a model of ovarian cancer: enhancement of effect by batimastat. Europ. J. Cancer, 33, 1114-1121 (1997).
4. CHEN, P., GEER, D.C., PODACK, E.R. and KSANDER, B., Tumor cells transfected with B7-1 and interleukin-12 cDNA induce protective immunity. Ann. N.Y. Acad. Sci., 795, 325-327 (1996).
5. CLERICI, M., SARIN, A., COFFMAN, R.L., WYNN, T.A., BLATT, S.P., HENDRIX, C.W., WOLF, S.F., SHEARER, G.M. and HENKART, P.A., Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc. nat. Acad. Sci. (Wash.), 91, 11811-11815 (1994).
6. CORTESINA, G., DESTEFANI, A., GIOVARELLI, M., BARIOGLIO, M.G., CAVALLO, G.P., JEMMA, C. and FORNI, G., Treatment of recurrent squamous cell carcinoma of the head and neck with low dose interleukin-2 injected perilymphatically. Cancer, 62, 2482-2485 (1988).
7. + mediated rejection of established tumors. Hum. Gene Ther., 8, 477-488 (1997).
8. LEMSCHOW, D.J., WALUNAS, T.L. and BLUESTONE, J.A., CD28/B7 system of T cell co-stimulation. Ann. Rev. Immunol., 14, 233-258 (1996).
9. LOTZE, M.T., ZITVOGEL, L., CAMPBELL, R., ROBBINS, P.D., ELDER, E., HALUSZCZAK, C., MARTIN, D., WHITESIDE, T.L., STORKUS, W.J. and TAHARA, H., Cytokine gene therapy of cancer using interleukin-12: murine and clinical trials. Ann. N.Y. Acad. Sci., 795, 440-454 (1996).
10. OGAWA, M., YU, W., KAZUNARI, U., IWASAKI, M., WIJESURIYA, R., TSUJIMURA, T., KUBO, T., FUJIWARA, H. and HAMAOKA, T., Multiple roles of interferon-γ in the mediation of interleukin 12-induced tumor regression. Cancer Res., 58, 2426-2432 (1998).
11. OSSINA, N.K., CANNAS, A., POWERS, V.C., FITZPATRICK, P.A., KNIGHT, J.D., GILBERT, J.R., SHEKHTMAN, E.M., TOMEI, L.D., UMANSKI, S.R. and KIEFER, M.C., Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J. Biol. Chem., 272, 16351-16357(1997).
12. PAGANIN, C., GEROSA, F., PERITT, D., PAIOLA, F., SCUPOLI, M.T., ASTEAMEZAGA, M., FRANK, J. and TRINCHIERI, G., Effect of interleukin-12 on the cytokine profile of human CD4 and Cd8 T cell clones. Ann. N.Y. Acad. Sci., 795, 382-383 (1996).
13. PAPPO, I., TAHARA, H., ROBBINS, P.D., GATELY, M.K., WOLF, S.F., BARNEA, A. and LOTZE, M.T., Administration of systemic or local interleukin-2 enhances the anti-tumor effects of interleukin-12 gene therapy. J. Surg. Res., 58, 218-226 (1995).
14. RASHLEIGH, S.P., KUSHER, D.I., ENDICOTT, J.N., ROSSI, A.R. and DJEU, J.Y., Interleukins 2 and 12 activate natural killer cytolytic responses of peripheral blood mononuclear cells from patients with head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg., 122, 541-547(1996).
15. ROSENBERG, S.A., YANG, J.C., TOPALIAN, S.L., SCHWARTZENTRUBER, D.J., WEBER, J.S., PARKINSON, D.R., SEIPP, C.A., EINHORN, J.H. and WHITE, D.E., Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-bolus interleukin-2. J. Amer. Med. Assoc., 271, 907-913 (1994).
16. SCHWARTZ, R.H., Models of T cell anergy: is there a common molecular mechanism? J. exp. Med., 184, 1-8 (1996).
17. SOIFFER, R.J., ROBERTSON, M.J., MURRAY, C., COCHRAN, K. and RITZ, J., Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies. Blood, 82, 2790-2796 (1993).
18. THOMAS, G.R., CHEN, Z., OECHSLI, M.N.. HENDLER, F.J. and VAN WAES, C., Decreased expression of CD80 is a marker for increased tumorigenicity in a new murine model of oral squamous carcinoma. Int. J. Cancer, 82, 377-384 (1999).
19. WHITESIDE, T.L. and 12 OTHERS, Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck. Cancer Res., 53, 5654-5662 (1993).
20. WIGGINGTON, J.M., KOMSCHLIES, K.L., BACK, T.C., FRANCO, J.L., BRUNDA, M.J. and WILTROUT, R.H., Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma. J. nat. Cancer Inst., 88, 38-43 (1996).
21. ZITVOGEL, L., ROBBINS, P.D., STORKUS, W.J., CLARKE, M.R., MAEURER, M.J., CAMPBELL, R.L., DAVIS, C.G., TAHARA, H., SCHREIBER, R.D. and LOTZE, M.T., Interleukin-12 and B7-1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors. Europ. J. Immunol., 26, 1335-1341 (1996).